Men’s Power-Pressure Wave Erectile Regeneration-Therapy: an Early Assessment

Abstract

Introduction: Low intensity extracorporeal shockwave therapy for erectile dysfunction (LISWT) has been well researched as a treatment for Erectile Dysfunction (ED) and used as a first line treatment in many parts of the world as a viable alternative to oral, on-demand, phosphodiesterase type 5 inhibitors (PDE5i). Though effective, these drugs have limitations and are associated with significant non-compliance, side effects and do not reverse the underlying pathology [1][2][3]. Non-invasive low intensity shockwave therapy (LISWT) has been shown to significantly improve erectile function in men previously PDE5i dependent.